BioAdaptives (BDPT) 10-Q2024 Q1 Quarterly report

Filed: 17 May 24, 4:10pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: absolute, acoustic, added, adding, aged, aggressively, aging, AI, aka, APAC, assume, athletic, attractive, auditor, BF, billion, blood, Body, buying, capture, choice, clear, cohort, Composition, construct, dealer, decided, declined, efficient, employment, endemic, environment, evolved, excellent, excluded, expend, exposed, expulsion, Extreme, fast, favorable, feasibility, formula, free, geriatric, good, great, greater, grow, haemorrhaging, holder, hospital, imminently, indirect, intangible, internationally, inventor, inventory, lack, leased, licensee, loosen, LungFlute, mail, mailing, medium, Mexico, Mobility, network, North, opportunity, Organization, owner, PCAOB, people, permanently, Pixcelcando, Poland, power, preliminary, protocol, recommend, Regen, register, regularly, relationship, resident, resistance, returned, salary, salespeople, seasoned, sector, segment, settle, short, similar, smoke, spending, Stanford, study, suspended, tobacco, topical, tranche, trial, turn, undertaken, undertook, University, view, viral, workable, wound

Removed: Additionally, advanced, alleviate, amazon, amended, amounted, assemble, assigned, augment, behalf, bioavailability, booster, CEO, Certification, channel, combination, commercial, complement, complementary, concentrate, concentrating, concentration, corroborated, Dated, demonstrated, deploy, desired, Diagonal, diffusion, dissolved, Dr, duly, Edward, embed, emerging, equipment, exit, explore, extending, feature, formulated, hemorrhaging, hierarchy, high, highest, identical, improvement, individual, ingestion, inspection, investigation, June, knowledge, launched, Lending, licensed, light, Liu, LY, maintain, marketed, measure, met, method, mood, mushroom, negotiating, Nevada, observability, older, orderly, participated, past, pilot, planned, PluriCell, Practice, premium, prevented, PrimiLive, PrimiLung, Pursuant, quoted, readily, recast, recommenced, recover, reformulated, Regina, registrant, rejuvenating, rejuvenation, revamping, revised, Robert, role, sample, satisfactory, Section, sell, SleepEZ, Sutton, technical, technique, terminated, thereunto, transaction, troubling, unadjusted, undersigned, unobservable, unwind, utilize, Wildpack, Yaguang

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BDPT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of BioAdaptives Inc. (the Registrant) on Form 10-Q for the period ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Edward E. Jacobs, Jr, Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to Edward E. Jacobs, Jr and will be retained by BioAdaptives Inc. and furnished to the Securities and Exchange Commission for or its staff upon request.

Dated: May 17, 2024		/s/ Edward E. Jacobs, Jr
		Edward E. Jacobs, Jr
		Chief Executive Officer
		(Principal Executive Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.